Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-2.81%||177.01||0.7%||$1390.13m|
|MRK||Merck & Co., Inc.||-2.60%||91.96||0.7%||$1216.80m|
|BMY||Bristol-Myers Squibb Co.||-1.58%||78.72||1.0%||$1104.13m|
|LLY||Eli Lilly & Co.||-2.91%||317.75||1.1%||$1091.72m|
|TPTX||Turning Point Therapeutics, Inc.||-0.28%||75.06||0.0%||$295.90m|
|HZNP||Horizon Therapeutics Plc||-4.45%||81.69||5.4%||$176.63m|
|MRTX||Mirati Therapeutics, Inc.||-1.67%||68.50||1.6%||$162.75m|
|NVO||Novo Nordisk A/S||-4.04%||108.33||0.1%||$145.58m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.47%||144.69||0.0%||$142.13m|
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.